This bill extends federal support for stem cell transplant and cord blood programs through 2031 and raises yearly funding for the transplant program. It shifts from a fixed stockpile goal to keeping enough high-quality, diverse cord blood for patient needs. It also lets the government move units from failing banks and manage supplies using current science, which could improve transplant access, quality, and efficiency.